Jessica Fung
Stock Analyst at JP Morgan
(1.23)
# 3,685
Out of 5,015 analysts
8
Total ratings
50%
Success rate
-2.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Fung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Neutral | $150 → $170 | $460.46 | -63.08% | 2 | Feb 1, 2024 | |
| UTHR United Therapeutics | Maintains: Overweight | $290 → $294 | $440.00 | -33.18% | 2 | Nov 2, 2023 | |
| FSM Fortuna Mining | Upgrades: Outperform | n/a | $8.85 | - | 4 | Mar 31, 2017 |
Alnylam Pharmaceuticals
Feb 1, 2024
Maintains: Neutral
Price Target: $150 → $170
Current: $460.46
Upside: -63.08%
United Therapeutics
Nov 2, 2023
Maintains: Overweight
Price Target: $290 → $294
Current: $440.00
Upside: -33.18%
Fortuna Mining
Mar 31, 2017
Upgrades: Outperform
Price Target: n/a
Current: $8.85
Upside: -